Streetbeat News

Revenues

EVGO

EVgo has reaffirmed its revenue guidance for 2024, projecting revenues to be in the range of $220 million to $270 million. This announcement confirms the company's previous forecasts and indicates confidence in its future financial performance.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:06 am

HBIO

Harvard Bioscience projects its 2024 gross margin at around 60% and adjusted EBITDA margin in the mid-teens, with revenues expected to be roughly the same as in 2023. Growth in the second half of 2024 is anticipated, driven by new product launches and improvements in China.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:06 am

CRNT

Ceragon Networks has reiterated its FY24 revenue guidance, projecting revenues to be in the range of $385M-$405M, which aligns closely with the analyst estimate of $394.127M.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:05 am

UE

Urban Edge Properties (UE) reported Q1 2024 AFFO of $0.33 per share, surpassing the $0.30 estimate, and sales of $109.626M, exceeding the $107.693M estimate. This represents a 3.13% increase in earnings and a 10.24% increase in sales over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:04 am

DDOG

Datadog projects its Q2 2024 revenue to be between $620M-$624M, closely aligning with the analyst estimate of $620.621M. The company also forecasts its adjusted EPS to range from $0.34 to $0.36, which brackets the analyst estimate of $0.35.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:03 am

CROX

Crocs forecasts its Q2 revenues to increase by 1-3% and expects its adjusted EPS to be between $3.40 and $3.55, compared to the estimated $3.47.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:03 am

DORM

Dorman Products projects its FY24 revenue to grow by 3% to 5%, with adjusted EPS forecasted to be between $5.40 and $5.70, compared to the estimated $5.55.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:03 am

HBIO

Harvard Bioscience reported Q1 adjusted earnings of $0.02 per share, meeting analyst estimates but marking a 66.67% decrease from last year. Sales were $24.51M, missing the $25.79M estimate and down 18.23% from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:03 am

DORM

Dorman Products (DORM) reported Q1 adjusted earnings of $1.31 per share, surpassing the $0.82 estimate, a 133.93% increase from last year. However, sales of $468.70M fell short of the $472.48M estimate, marking a slight 0.42% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:01 am

USAC

USA Compression Partners has reaffirmed its FY24 financial outlook, projecting a net income of $95M-$115M and an Adjusted EBITDA of $555M-$575M.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 10:59 am